Clinical Trial Update: Gene Therapy With hLB-001 in Pediatric Patients With Severe Methylmalonic Acidemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of gene therapy hLB-001 in pediatric patients with methylmalonic acidemia has terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methylmalonic Acidemia

Drugs mentioned

• hLB-001

Snippet

Sponsor: LogicBio Therapeutics, Inc | Conditions: Methylmalonic Acidemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-02-23